Reflections on the Cost of 'Low Cost' Whole Genome Sequencing: Framing the Health Policy Debate

Media type: E-Book

Title: Reflections on the Cost of 'Low Cost' Whole Genome Sequencing : Framing the Health Policy Debate

Contributor: Caulfield, Timothy [Author]; Evans, James P. [Author]; McGuire, Amy L. [Author]; McCabe, Christopher [Author]; Bubela, Tania [Author]; Cook-Deegan, Bob [Author]; Fishman, Jennifer [Author]; Hogarth, Stuart [Author]; Miller, Fiona A. [Author]; Ravitsky, Vardit [Author]; Biesecker, Barbara [Author]; Borry, Pascal [Author]; Cho, Mildred K. [Author]; Carroll, June [Author]; Etchegary, Holly [Author]; Joly, Yann [Author]; Kato, Kazuto [Author]; Lee, Sandra [Author]; Rothenberg, Karen H. [Author]; Sankar, Pamela [Author]; Szego, Michael [Author]; Ossorio, Pilar [Author]; Pullman, Daryl [Author]; Rousseau, Francois [Author]; Ungar, Wendy [Author]; Wilson, Brenda [Author]

Published: [S.l.]: SSRN, 2014

Extent: 1 Online-Ressource (6 p)

Language: English

Origination:

Footnote: In: PLOS Biology, V. 11, No. 11, November 2013, p. e1001699
Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments November 1, 2013 erstellt

Description: The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy

Access State: Open Access

Search in field:

Recently searched for: